Palmoplantar pustulosis rare, linked to psoriasis
Researchers recently undertook an epidemiologic study to investigate the prevalence of palmoplantar pustulosis (PPP) and co-existing plaque psoriasis. Read what they discovered in this article.
Comorbidities more prevalent in pediatric psoriasis patients
Pediatric psoriasis patients may experience comorbidities, including psychiatric comorbidities, at a greater rate than children without the disease, according to a recent study.
How does diet, oral health influence psoriasis?
Oral health, habits and diet may influence disease severity in psoriasis, says a study published in the Dermatology Online Journal.
Does gluten intake influence psoriasis, psoriatic arthritis?
A recent study examined whether gluten intake in adulthood increases the risk of developing psoriasis, psoriatic arthritis, and atopic dermatitis.
Is psoriasis a risk factor for cardiometabolic disease in women?
It is well established that psoriasis is associated with cardiometabolic disease, though the reason why remains unclear. This study followed pregnant women and mothers with psoriasis over an 11 year period to gain insight into the link between the immune-mediated skin disease and cardiometabolic disease.
Pruritus characteristics in psoriasis
Pruritus frequently afflicts psoriasis patients, but few studies explore the role of pruritus in regards to disease activity, pharmacotherapy or demographics. This study attempts to fill that gap.
Apremilast appears safe for children with psoriasis
Weight-based dosing of apremilast appeared to ensure comparable efficacy, safety and tolerability with in kids as in adults, and should be explored in future studies.
Early ustekinumab levels may influence psoriasis treatment response
Study shows measurement of early ustekinumab levels could be used to direct treatment strategy in psoriasis.
The psoriasis – Type 2 diabetes connection
Psoriasis has been strongly linked to metabolic and Type 2 diabetes, but the exact relationship between psoriasis and Type 2 diabetes remains ambiguous. This study aimed to fill that gap.
Screening psoriasis patients for psoriatic arthritis
This slideshow breaks down important considerations to keep in mind when evaluating psoriasis patient for psoriatic arthritis.
High blood pressure risk in psoriasis, psoriatic arthritis
A recent study discovered that body mass index (BMI) and age of disease onset may play a part in the development of hypertension in psoriatic arthritis and psoriasis. Read what researchers found in this article.
Behavioral modifications may reduce psoriasis severity
Researchers in Taiwan investigated whether behavioral modifications such as weight reduction, alcohol abstinence, smoking cessation and exercise could impact psoriasis severity. Read what they discovered in this article.
Joint AAD, NPF phototherapy guidelines
Discover key takeaways from the American Academy of Dermatology and National Psoriasis Foundation joint guidelines for the management and treatment of psoriasis with phototherapy published in the September issue of the Journal of American Academy of Dermatology.
Sleep problems common in psoriasis
Researchers employed the the Citizen Pscientist, an online patient portal developed by the National Psoriasis Foundation, to investigate chronic sleep dysfunction prevalence in psoriasis. Read what they discovered in this article.
Patient satisfaction in psoriasis
There are more treatment options for psoriasis patients than ever before, so why do patient reported outcomes still suggest failure to meet patient expectations? Experts from the International Psoriasis Council (IPC) highlight factors that could be causing the perceived disparity between psoriasis treatment and patient satisfaction.
Can psychotherapy help psoriasis patients?
Do you recommend psychotherapy to your psoriasis patients? While there is a well-established connection between psoriasis and mental health, there is little data available on the impact of psychological interventions on psoriasis. These study authors look to fill that gap.
Quiz: Case studies in psoriasis
Test your knowledge by answering these five questions about different psoriasis cases.
New tool to identify psoriatic arthritis
A recent study found that Psoriasis Epidemiology Screening Tool (PEST) may help dermatologists identify which patients need a rheumatology referral.
Racial disparities in psoriasis treatment
A recent study explored why black individuals with psoriasis are disproportionately under treated. Authors compared differences in the perceptions and understanding of psoriasis therapies in both black and Caucasian patients. Here’s what they found.
Brodalumab effective for psoriasis patients with skin of color
Psoriasis patients with skin of color experience psoriasis differently, often reporting worse health related quality of life outcomes compared to their Caucasian peers. Brodalumab may help, suggests a recent study.
The prevalence of incidentalomas in psoriasis
A recent study aimed to explore whether patients suffering from psoriasis carry serious medical morbidity, including cancer, that is not detected through history, physical exam and laboratory studies.
Psoriatic arthritis associated with hearing impairment
According to a recent study, patients with psoriatic arthritis may be at a greater risk for adult hearing loss than individuals without psoriatic arthritis.
Optimal levels of ustekinumab
Researchers found a significant inverse correlation between ustekinumab levels and PASI scores at week 52, suggesting that drug levels are associated with the change in the treatment response. Measuring ustekinumab levels can have major clinical implications.
Utility of the methotrexate test dose
Guidelines suggest that providing a small test dose of methotrexate to patients followed by laboratory evaluation can minimize the risk of serious adverse events associated with methotrexate. This small retrospective study examined whether methotrexate requires a test dose.
Tyrosine Kinase 2 inhibitors: A phase 2 trial in psoriasis
Researchers recently performed a control trial to test the efficacy of BMS-986165 a potent TYK2 inhibitor. Here's what they found.
Understanding psoriasis induced by TNF-a inhibition
Researchers at The Cleveland Clinic Lerner College of Medicine recently explored the development of a psoriasiform rash in patients with inflammatory bowel disease or rheumatoid arthritis who were treated with TNF-ɑ inhibitors. Learn what they discovered in this article.
Is thyroid endocrinopathy associated with psoriasis?
A recent study suggests that patients suffering from psoriasis and psoriatic arthritis may have an increased risk of developing autoimmune thyroid disease.
Psoriasis and inflammatory bowel disease as one unit
Having psoriasis gives a patient a 1.75-fold increased odds of developing ulcerative colitis and a 1.70-fold increased odds of developing Crohn's disease.
Ustekinumab sometimes associated with interstitial lung disease
Doctors should be vigilant about recognizing the signs and symptoms of patients who may develop ILD in order to prevent catastrophic complications, such as respiratory failure.
Patients with psoriasis may not live as long
Increased mortality described in the first study to review all-cause mortality and cause-specific mortality in patients with psoriasis.
2 Clarke Drive Cranbury, NJ 08512